Abstract
Background: Antibiotic-loaded bone cement (ALBC) is used to deliver antimycobacterial agents into the focal lesion of musculoskeletal tuberculosis. Although kanamycin is currently used as an antimycobacterial agent for the treatment of multidrug-resistant tuberculosis, there is no information about its suitability in ALBC. Methods: An in vitro experiment was conducted with cylindrical shape of 40 g of bone cement with 1, 2, and 3 g of kanamycin. Eluate (1 mL) was extracted from each specimen to measure the level of elution and antimycobacterial activity on days 1, 4, 7, 14, and 30. The quantity of kanamycin in eluates was evaluated by a liquid chromatography-mass spectrometry system, and the antimycobacterial activity of eluates against Mycobacterium tuberculosis H37Rv was calculated by comparing the minimal inhibitory concentration. The ultimate compression strength was conducted using a material testing system machine (Instron 3366; Instron, Norwood, MA) before and after elution. Results: Eluates from ALBC containing 2 and 3 g of kanamycin had effective antimycobacterial activity for 30 days, whereas eluates from ALBC containing 1 g of kanamycin were partially active until day 30. The pre-eluted compression strength of kanamycin-loaded cement and vancomycin-loaded cement was weaker as they contained a larger amount of antibiotics. There was no statistical difference between the strength of all kanamycin regimens and 1 g of vancomycin in the ultimate compression test. After 30 days of elution, the strength of all kanamycin-loaded cement and vancomycin-loaded cement cylinders was significantly lower than that of initial specimens (P < .05). Conclusion: The antimycobacterial activity of ALBC containing more than 2 g of kanamycin was effective during a 30-day period. The ultimate compression strength of bone cement loaded with 1-3 g of kanamycin was comparable with 1 g of vancomycin while maintaining effective elution until day 30.
| Original language | English |
|---|---|
| Pages (from-to) | 864-869 |
| Number of pages | 6 |
| Journal | Journal of Arthroplasty |
| Volume | 35 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2020 Mar |
Bibliographical note
Funding Information:The authors thank Chang Hoon Park (Clinical Trials Center, Severance Hospital) and Brain Korea 21 Project for their support in their experiments. This study was supported by a faculty research grant of Yonsei University College of Medicine, South Korea (6-2017-0156).
Funding Information:
The authors thank Chang Hoon Park (Clinical Trials Center, Severance Hospital) and Brain Korea 21 Project for their support in their experiments. This study was supported by a faculty research grant of Yonsei University College of Medicine, South Korea ( 6-2017-0156 ). Appendix A
Publisher Copyright:
© 2019 Elsevier Inc.
All Science Journal Classification (ASJC) codes
- Orthopedics and Sports Medicine
